These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3344743)

  • 21. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria.
    Iwalokun BA; Hodonu SO; Olaleye BM; Olabisi OA
    Afr J Med Med Sci; 2006 Sep; 35(3):337-43. PubMed ID: 17312742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological dynamics of hepatitis B virus load in dialysis population.
    Fabrizi F; Lunghi G; Alongi G; Bisegna S; Campolo G; Mangano S; Limido A; Pagliari B; Tettamanzi F; Ponticelli C
    Am J Kidney Dis; 2003 Jun; 41(6):1278-85. PubMed ID: 12776281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area.
    Ruggiero G; Cesaro G; Mazzella C; Gaeta GB; Miraglia E; Mastrullo L; Boffa ML; Spiteri D; Schiattarella V; de Biasi R
    Hepatogastroenterology; 1985 Apr; 32(2):57-60. PubMed ID: 4007763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
    Ningyu Z; Ying Z; Hui L
    J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in European patients with the hepatitis B surface antigen.
    Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
    N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum iron levels and response to hepatitis B virus.
    Felton C; Lustbader ED; Merten C; Blumberg BS
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2438-41. PubMed ID: 287082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study.
    Chiu YM; Lai MS; Chan KA
    Arthritis Res Ther; 2017 Nov; 19(1):214. PubMed ID: 29089055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of renal transplantation in hepatitis B surface antigen-positive patients in cyclosporin era.
    Yagisawa T; Toma H; Tanabe K; Ishikawa N; Tokumoto N; Iguchi Y; Goya N; Nakazawa H; Takahashi K; Ota K
    Am J Nephrol; 1997; 17(5):440-4. PubMed ID: 9382163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
    Tiku ML; Beutner KR; Tiku K; Ogra PL
    J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.
    Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ
    Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B surface antigen in late hepatitis B infection.
    Zeng DW; Zhu YY; Huang Q; Zhang JM; Wu YL; Dong J; Jiang JJ; Liu YR
    J Med Virol; 2015 Mar; 87(3):380-7. PubMed ID: 25604455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?
    Kanbay M; Gur G; Akcay A; Selcuk H; Yilmaz U; Arslan H; Boyacioglu S; Ozdemir FN
    Dig Dis Sci; 2006 Nov; 51(11):1962-6. PubMed ID: 16977505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients.
    Parfrey PS; Farge D; Forbes RD; Dandavino R; Kenick S; Guttmann RD
    Kidney Int; 1985 Dec; 28(6):959-67. PubMed ID: 3936966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients.
    Elgohry I; Elbanna A; Hashad D
    Clin Lab; 2012; 58(9-10):1057-61. PubMed ID: 23163124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host responses to hepatitis B infection in patients in a chronic hemodialysis unit.
    London WT; Drew JS; Lustbader ED; Werner BG; Blumberg BS
    Kidney Int; 1977 Jul; 12(1):51-8. PubMed ID: 894916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous clearance of hepatitis B surface antigenemia after long-term hemodialysis.
    Patel C; Monga D; Alexander M; Magoon S; Bernstein D; Wagner JD; Mattana J
    Semin Dial; 2014; 27(1):57-9. PubMed ID: 24131219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
    Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
    Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Yaşar DG; Suyanı E; Özenirler S; Sucak GT
    Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.